{"id":787,"date":"2026-10-20T03:32:16","date_gmt":"2026-10-20T01:32:16","guid":{"rendered":"http:\/\/novameds.local\/de\/?post_type=product&#038;p=787"},"modified":"2026-10-20T04:00:25","modified_gmt":"2026-10-20T02:00:25","slug":"catalog-tesamorelin-2mg","status":"publish","type":"product","link":"https:\/\/novameds.health\/de\/produkt\/catalog-tesamorelin-2mg\/","title":{"rendered":"Tesamorelin, 2mg"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Zusammensetzung und Produktdetails\">\n<h2>Zusammensetzung und Produktdetails<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>\u00dcbersicht<\/h2>\n<div>\n<p>Tesamorelin 2 mg provides one individually sealed lyophilised vial of the synthetic GHRH analogue, suited for preclinical GH axis research, GHRHR agonist studies, and controlled laboratory protocols requiring a single 2 mg research vial.<\/p>\n<p>Tesamorelin\u2019s trans-3-hexenoic acid N-terminal modification confers DPP-IV resistance and an extended half-life of approximately 26\u201338 minutes compared to around 7 minutes for native GHRH, while preserving full GHRHR agonist activity. The single-vial format is suitable for smaller-scale experiments, pilot studies, or protocols that do not require a multi-vial kit.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<p><a href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/16137828\" target=\"_blank\" rel=\"noopener noreferrer\">Molekulardaten bei PubChem<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>Eigenschaften<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C221H366N72O67S<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>TH9507, Egrifta (trade name)<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>5,135.86 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>218949-48-5<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>16137828<\/td>\n<\/tr>\n<tr>\n<th>Verf\u00fcgbare Formate<\/th>\n<td>1 vial \u00b7 KIT (10 vials)<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Forschung<\/h2>\n<p>Tesamorelin 2 mg contains one lyophilised vial of research-grade synthetic GHRH analogue. It is designed for laboratory research involving GHRHR agonist activity, GH\/IGF-1 axis signaling, and related preclinical study models.<\/p>\n<p>Tesamorelin acts through GHRHR-mediated Gs\u03b1\/cAMP\/PKA signaling associated with growth hormone release. Its DPP-IV-resistant structure and extended plasma half-life of approximately 26\u201338 minutes make it useful for research protocols examining modified GHRH analogues and downstream GH\/IGF-1 axis activation.<\/p>\n<p>The single-vial format is particularly suited to exploratory studies, single-condition experiments, pilot protocols, or researchers who require a smaller quantity before scaling into larger study designs. Independently third-party HPLC-tested; COA available per batch.\t\t\t\t\t<\/p><\/div>\n<div>\n<h2>Laborergebnisse<\/h2>\n<p>Results refer to the tested sample. Check the batch and date in the report.<\/p>\n<div>\n<div>\n<div><\/div>\n<div>\n<div>Tesamorelin (HPLC)<\/div>\n<div>September 13, 2026<\/div>\n<\/p><\/div>\n<div><a href=\"https:\/\/swisschems.is\/wp-content\/uploads\/2026\/06\/HPLC-Tesamorelin-2607-ED-TE.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Open PDF<\/a><span> \u00b7 <\/span><a href=\"https:\/\/coas.freedomdiagnosticstesting.com\/IMT2609110400.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Laboratory source<\/a><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>Why is matched-batch compound important for longitudinal Tesamorelin research studies?<\/span><\/p>\n<\/summary>\n<div>\n<p>Tesamorelin is a 44-amino-acid peptide whose biological activity depends on precise sequence integrity and correct folding post-reconstitution. Between-batch variation in peptide synthesis can produce minor differences in impurity profiles and residual protecting group content that may affect receptor activation kinetics.<\/p>\n<p>For longitudinal studies where baseline and endpoint measurements are separated by weeks or months, using matched-batch material from the same KIT eliminates inter-batch variation as a confounding variable \u2014 a methodological advantage relevant to studies measuring quantitative GHRHR pathway endpoints.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is the recommended reconstitution volume for Tesamorelin 2 mg vials for preclinical use?<\/span><\/p>\n<\/summary>\n<div>\n<p>Reconstitution volume depends on the desired working concentration for the specific study design. A common laboratory approach is to reconstitute in 1\u20132 ml bacteriostatic water to produce a 1\u20132 mg\/ml stock solution. For rodent studies, this is then diluted to the required dose in physiological saline or BAC water.<\/p>\n<p>Researchers should prepare only the volume needed for immediate use, as reconstituted peptide solutions are most stable within 24\u201348 hours at 4\u00b0C and should not be subjected to repeated freeze-thaw cycles.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is Tesamorelin 2 mg used for in research?<\/span><\/p>\n<\/summary>\n<div>\n<p>Tesamorelin 2 mg is used in laboratory research involving growth hormone-releasing hormone receptor activity, GH\/IGF-1 axis signaling, and related preclinical study models. It is intended strictly for research use only and is not for human consumption.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Tesamorelin 2 mg provides one individually sealed lyophilised vial of the synthetic GHRH analogue, suited for preclinical GH axis research, GHRHR agonist studies, and controlled laboratory protocols requiring a single 2 mg research vial.<\/p>\n<p>Darreichungsform: Tesamorelin, 2mg.<\/p>\n<p>Gew\u00fcnschte St\u00e4rke und Packungsgr\u00f6\u00dfe ausw\u00e4hlen.<\/p>\n<p class=\"nm-research-disclaimer\">Nur f\u00fcr die Laborforschung. Nicht zur Anwendung bei Menschen oder Tieren.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Mit KI erstellte illustrative Verpackung.<\/small><\/p>\n","protected":false},"featured_media":958,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[26],"product_tag":[],"nm_classification":[],"class_list":["post-787","product","type-product","status-publish","has-post-thumbnail","product_cat-recovery-regeneration","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"_links":{"self":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product\/787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/comments?post=787"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/media\/958"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/media?parent=787"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product_brand?post=787"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product_cat?post=787"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/product_tag?post=787"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/de\/wp-json\/wp\/v2\/nm_classification?post=787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}